Distinctive immunohistochemical profile of mucinous cystic neoplasms of pancreas, ovary and lung

Histology and Histopathology

Volumn 24, Issue 1, 2009, Pages 77-82

  Silverman, Jan F ^a   Zhu, Bing ^b   Liu, Yulin ^a   Lin, Xiaoqi ^b  

^a ALLEGHENY GENERAL HOSPITAL   (United States)

^b NORTHWESTERN MEMORIAL HOSPITAL   (United States)

Author keywords

Immunohistochemistry; Lung; Mucinous cystic neoplasm; Ovary; Pancreas

Indexed keywords

CA 125 ANTIGEN; CYTOKERATIN 20; CYTOKERATIN 7; MONOCLONAL ANTIBODY D2-40; THYROID TRANSCRIPTION FACTOR 1; TRANSCRIPTION FACTOR CDX2; TRANSCRIPTION FACTOR PDX 1; TUMOR MARKER; WT1 PROTEIN; CDX 2 3 PROTEIN; CDX-2-3 PROTEIN; HOMEODOMAIN PROTEIN; INSULIN PROMOTER FACTOR 1; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER GRADING; CANCER INVASION; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG CARCINOMA; MAJOR CLINICAL STUDY; MALE; MUCINOUS CARCINOMA; OVARY CARCINOMA; PANCREAS CARCINOMA; PROTEIN EXPRESSION; UTERINE CERVIX CARCINOMA; BIOSYNTHESIS; COLLOID CARCINOMA; LUNG TUMOR; METABOLISM; METASTASIS; MIDDLE AGED; OVARY TUMOR; PANCREAS TUMOR;

ADENOCARCINOMA, MUCINOUS; ADULT; AGED; CA-125 ANTIGEN; FEMALE; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; KERATIN-20; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; OVARIAN NEOPLASMS; PANCREATIC NEOPLASMS; TRANS-ACTIVATORS; TUMOR MARKERS, BIOLOGICAL;

EID: 60549084021     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Albores-Saavedra J., Angeles-Angeles A., Nadji M., Henson D.E. and Alvarez L. (1987). Mucinous cystadenocarcinoma of the pancreas. Morphologic and immunocytochemical observations. Am. J. Surg. Pathol. 11, 11-20.
2. Ashizawa S., Brunicardi F.C. and Wang X.P. (2004). PDX-1 and the pancreas. Pancreas 28, 109-120.
3. Bloomston M., Chanona-Vilchis J., Ellison E..C, Ramirez N.C. and Frankel W.L. (2006). Carcinosarcoma of the pancreas arising in a mucinous cystic neoplasm. Am. Surg. 72, 351-355.
4. Cathro H.P. and Stoler M.H. (2002). Expression of cytokeratins 7 and 20 in ovarian neoplasia. Am. J. Clin. Pathol. 117, 944-951.
5. Colby T.V., Ohori P., Noguchi M., Rami-Porta R., Henschke C., Franks T., Vazquez M.R., Schimosato Y., Geisinger K. and Matsuno Y. (2004). Adenocarcinoma. In: Pathology and genetics: Tumors of the lung, pleura, thymus and heart. Travis W.D., Brambilla E., Muller-Hermelink H.K. and Harris C.C. IARC Press. Lyon, France. pp 40.
6. Davison A.M., Lowe J.W. and Da Costa P. (1992). Adenocarcinoma arising in a mucinous cystadenoma of the lung. Thorax 47, 129-130.
7. Devaney K., Kragel P. and Travis W. (1989). Mucinous cystadenocarcinoma of the lung: A tumor of low malignant potential (abstr). Am. J. Clin. Pathol. 92, 524 (Abstract).
8. Dixon A.Y., Moran J.F., Wesselius L.J. and McGregor D.H. (1993). Pulmonary mucinous cystic tumor. Case report with review of the literature. Am. J. Surg. Pathol. 17, 722-728.
9. Gaeta M., Blandino A., Scribano E., Ascenti G., Minutoli F. and Pandolfo I. (1999). Mucinous cystadenocarcinoma of the lung: CT-pathologic correlation in three cases. J. Comput. Assist. Tomogr. 23, 641-643.
10. Gao Z.H. and Urbanski S.J. (2005). The spectrum of pulmonary mucinous cystic neoplasia: a clinicopathologic and immunohistochemical study of ten cases and review of literature. Am. J. Clin. Pathol. 124, 62-70.
11. Graeme-Cook F. and Mark E.J. (1991). Pulmonary mucinous cystic tumors of borderline malignancy. Hum. Pathol. 22, 185-190.
12. Hart W.R. (2005) Mucinous tumors of the ovary: a review. Int. J. Gynecol. Pathol. 24, 4-25.
13. Hart W.R. and Norris H.J. (1973). Borderline and malignant mucinous tumors of the ovary. Histologic criteria and clinical behavior. Cancer 31, 1031-1045.
14. Honma N., Sakamoto G., Ikenaga M., Kuroiwa K., Younes M. and Takubo K. (2003). Mucinous cystadenocarcinoma of the breast: a case report and review of the literature. Arch. Pathol. Lab. Med. 127, 1031-1033.
15. Hruban R.H., Pitman M.B. and Klimstra D.S. (2007). Mucinous Cystic Neoplasms. In: Tumors of the pancreas. Hruban R.H., Pitman M.B. and Klimstra D.S. (eds). American Registry of Pathology in Collaboration with the Armed Forces Institute of Pathology. Washington, DC. pp 51-74.
16. Hui H. and Perfetti R. (2002). Pancreas duodenum homeobox-1 regulates pancreas development during embryogenesis and islet cell function in adulthood. Eur. J. Endocrinol. 146, 129-141.
17. Jin T. and Drucker D.J. (1996). Activation of proglucagon gene transcription through a novel promoter element by the caudal-related homeodomain protein cdx-2/3. Mol. Cell. Biol. 16, 19-28.
18. Kaimaktchiev V., Terracciano L., Tornillo L., Spichtin H., Stoios D., Bundi M., Korcheva V., Mirlacher M., Loda M. and Sauter G. (2004). The homeobox intestinal differentiation factor CDX2 is selectively expressed in gastrointestinal adenocarcinomas. Mod. Pathol. 17, 1392-1399.
19. Lau S.K., Desrochers M.J. and Luthringer D.J. (2002). Expression of thyroid transcription factor-1, cytokeratin 7, and cytokeratin 20 in bronchioloalveolar carcinomas: an immunohistochemical evaluation of 67 cases. Mod. Pathol. 15, 538-542.
20. Lee K., Tavassoli F., Prat J., Dietel M., Gersell D., Karseladze A., Hauptmann S. and Rutgers J. (2003). Surface epithelial-stromal tumors. In: Pathology and genetics: Tumors of the breast and female genital organs. Tavassoli F.A. and Devilee P. (eds). IARC Press. Lyon, France. pp 124-129.
21. Mann G.N., Wilczynski S.P., Sager K. and Grannis F.W. Jr (2001). Recurrence of pulmonary mucinous cystic tumor of borderline malignancy. Ann. Thorac. Surg. 71, 696-697.
22. Monaghan H., Salter D.M. and Ferguson T. (2002). Pulmonary mucinous cystic tumour of borderline malignancy: a rare variant of adenocarcinoma. J. Clin. Pathol. 55, 156.
23. Moskaluk C.A., Zhang H., Powell S.M., Cerilli L.A., Hampton G.M. and Frierson H.F. Jr (2003). Cdx2 protein expression in normal and malignant human tissues: an immunohistochemical survey using tissue microarrays. Mod. Pathol. 16, 913-919.
24. Nakamura H., Tanaka Y., Hori H., Ishiguro S., Hara H. and Mori T. (1993). A case of mucinous cystic adenocarcinoma of the lung with signet-ring cells. Kyobu. Geka. 46, 990-993.
25. Offield M.F., Jetton T.L., Labosky P.A., Ray M., Stein R.W., Magnuson M.A., Hogan B.L. and Wright C.V. (1996). PDX-1 is required for pancreatic outgrowth and differentiation of the rostral duodenum. Development 122, 983-995.
26. Park S.Y., Kim H.S., Hong E.K. and Kim W.H. (2002). Expression of cytokeratins 7 and 20 in primary carcinomas of the stomach and colorectum and their value in the differential diagnosis of metastatic carcinomas to the ovary. Hum. Pathol. 33, 1078-1085.
27. Rossi G., Murer B., Cavazza A., Losi L., Natali P., Marchioni A., Migaldi M., Capitanio G. and Brambilla E. (2004). Primary mucinous (so-called colloid) carcinomas of the lung: a clinicopathologic and immunohistochemical study with special reference to CDX-2 homeobox gene and MUC2 expression. Am. J. Surg. Pathol. 28, 442-452.
28. Roux F.J., Lantuejoul S., Brambilla E. and Brambilla C. (1995). Mucinous cystadenoma of the lung. Cancer 76, 1540-1544.
29. Saad R.S., Cho P., Silverman J.F. and Liu Y. (2004). Usefulness of Cdx2 in separating mucinous bronchioloalveolar adenocarcinoma of the lung from metastatic mucinous colorectal adenocarcinoma. Am. J. Clin. Pathol. 122, 421-427.
30. Scully R., Roung R. and Clement P. (1998). Tumors of the ovary, maldeveloped gonads, fallopian tube, and broad ligmane. Armed Forces Institute of Pathology. Washington, DC. pp 23.
31. Silberg D.G., Swain G.P., Suh E.R. and Traber P.G. (2000). Cdx1 and cdx2 expression during intestinal development. Gastroenterology 119, 961-971.
32. Simsir A., Wei X.J., Yee H., Moreira A. and Cangiarella J. (2004). Differential expression of cytokeratins 7 and 20 and thyroid transcription factor-1 in bronchioloalveolar carcinoma: an immunohistochemical study in fine-needle aspiration biopsy specimens. Am. J. Clin. Pathol. 121, 350-357.
33. Tangthangtham A., Chonmaitri I., Tungsagunwattana S. and Charupatanapongse U. (1998) Mucinous cystadenocarcinoma of the lung. J. Med. Assoc. Thai. 81, 794-798.
34. Thompson L.D., Becker R.C., Przygodzki R.M., Adair C.F. and Heffess C.S. (1999). Mucinous cystic neoplasm (mucinous cystadenocarcinoma of low-grade malignant potential) of the pancreas: a clinicopathologic study of 130 cases. Am. J. Surg. Pathol. 23, 1-16.
35. Tsuta K., Ishii G., Nitadori J., Murata Y., Kodama T., Nagai K. and Ochiai A. (2006). Comparison of the immunophenotypes of signetring cell carcinoma, solid adenocarcinoma with mucin production, and mucinous bronchioloalveolar carcinoma of the lung characterized by the presence of cytoplasmic mucin. J. Pathol. 209, 78-87.
36. Wauters C.C., Smedts F., Gerrits L.G., Bosman F.T. and Ramaekers F.C. (1995). Keratins 7 and 20 as diagnostic markers of carcinomas metastatic to the ovary. Hum. Pathol. 26, 852-855.
37. Werling R.W., Yaziji H., Bacchi C.E. and Gown A.M. (2003). CDX2, a highly sensitive and specific marker of adenocarcinomas of intestinal origin: an immunohistochemical survey of 476 primary and metastatic carcinomas. Am. J. Surg. Pathol. 27, 303-310.
38. Zamboni G., Scarpa A., Bogina G., Iacono C., Bassi C., Talamini G., Sessa F., Capella C., Solcia E. and Rickaert F. (1999). Mucinous cystic tumors of the pancreas: clinicopathological features, prognosis, and relationship to other mucinous cystic tumors. Am. J. Surg. Pathol. 23, 410-422.
39. Zamboni G., Longnecker D., Kloppel G., Adler G. and Hruban R. (2000). Mucinous cystic neoplasms of the pancreas. In: Pathology and genetics: Tumors of the digestive system. Hamilton S.R. and Aaltonen L.A. (eds). IARC Press. Lyon, France. pp 234-236.